The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 2, 2021 / Schall Law Firm, a national law firm specializing in shareholder rights, is reminding investors of a class action lawsuit against Provenion Bio, Inc. (“Provention” or “the Company”) (NASDAQ: PRVB) for violating Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b-5, which were published by the Securities and Exchange Commission.

Investors who acquired the Company’s securities between November 2, 2020 and April 8, 2021 inclusive (the “Class Period”) are advised to contact the Company before July 20, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also contact us on the firm’s website at or by email at [email protected]

In this case, the class has not yet been certified and you will not be represented by a lawyer until certified. If you do nothing, you can remain an absent class member.

According to the lawsuit, the company provided false and misleading information to the market. Prevention’s Biologics License Application (‘BLA’) for teplizumab was flawed and required additional data to be submitted in order to obtain FDA approval. The teplizumab BLA lacked the compelling evidence and support that the company was leading the market to believe. The company has overstated the chances of getting teplizumab BLA approval and its commercial timeline. Because of these facts, the company’s public statements were false and materially misleading throughout the course period. When the market learned the truth about prevention, investors suffered damage.

Join the case to make up for your losses.

The law firm Schall represents investors worldwide and specializes in securities class actions and shareholder disputes.

The story goes on

This news release may be viewed as a solicitation in some jurisdictions under applicable law and ethical rules.

The Schall law firm
Brian Schall, Esq.,
Office: 310-301-3335
[email protected]

SOURCE: The Schall law firm

View source version on Firm-Reminds-Investors-of-a-Class-Action-Lawsuit-Against-Provention-Bio-Inc-and- Encouraged -Contact-investors-with-losses-in-excess-of-100,000-the-company

Comments are closed.